Photo by Austin Distel on Unsplash
The Acquired Podcast, one of the best business deep-dive podcasts out there just did an article on Novo Nordisk, the company behind Semaglutide (i.e. Ozempic, Wegovy, etc).
The podcast is awesome, and it's a great deep dive into the over 100 years of innovation coming out of Denmark.
With the recent wave of GLP1 Receptor Agonists gaining popularity, it's great to learn more about the company and their history.
This was originally posted on GLP1.guide
Top comments (0)